Cough syrup row: Delhi govt bans sale, distribution of Coldrif; warns public against use due to health risks | Delhi News
NEW DELHI: The Delhi government has banned the sale, purchase and distribution of Coldrif cough syrup after it was declared “not of standard quality”, an official order said.The order issued on Friday stated that Coldrif Syrup (Paracetamol, Phenylephrine Hydrochloride, Chlorpheniramine Maleate), manufactured in May 2025 by Sresan Pharmaceutical Manufacturer, Tamil Nadu, was found adulterated with Diethylene Glycol (46.28% w/v), a toxic chemical harmful to human health.
All stakeholders have been directed to immediately halt the sale, purchase, or distribution of this batch. The public has been warned not to use the product due to potential health risks.Authorities have urged all stakeholders to ensure strict compliance and widely circulate the advisory, issued in the interest of public safety.(With agencies inputs)
